nodes	percent_of_prediction	percent_of_DWPC	metapath
Nafarelin—Seborrhoeic dermatitis—Epirubicin—sarcoma	0.00513	0.00513	CcSEcCtD
Nafarelin—Dysuria—Thiotepa—sarcoma	0.00509	0.00509	CcSEcCtD
Nafarelin—Weight increased—Thiotepa—sarcoma	0.00496	0.00496	CcSEcCtD
Nafarelin—Muscular weakness—Vincristine—sarcoma	0.00493	0.00493	CcSEcCtD
Nafarelin—Seborrhoeic dermatitis—Doxorubicin—sarcoma	0.00475	0.00475	CcSEcCtD
Nafarelin—Vaginal haemorrhage—Epirubicin—sarcoma	0.00472	0.00472	CcSEcCtD
Nafarelin—Conjunctivitis—Thiotepa—sarcoma	0.00472	0.00472	CcSEcCtD
Nafarelin—Sweating increased—Mitoxantrone—sarcoma	0.00458	0.00458	CcSEcCtD
Nafarelin—Epistaxis—Thiotepa—sarcoma	0.00458	0.00458	CcSEcCtD
Nafarelin—Pleural effusion—Epirubicin—sarcoma	0.00457	0.00457	CcSEcCtD
Nafarelin—Dysuria—Vincristine—sarcoma	0.00452	0.00452	CcSEcCtD
Nafarelin—Vaginal haemorrhage—Doxorubicin—sarcoma	0.00437	0.00437	CcSEcCtD
Nafarelin—Weight decreased—Vincristine—sarcoma	0.00437	0.00437	CcSEcCtD
Nafarelin—Depression—Vincristine—sarcoma	0.0043	0.0043	CcSEcCtD
Nafarelin—Weight increased—Mitoxantrone—sarcoma	0.00428	0.00428	CcSEcCtD
Nafarelin—Weight decreased—Mitoxantrone—sarcoma	0.00426	0.00426	CcSEcCtD
Nafarelin—Acute coronary syndrome—Vincristine—sarcoma	0.00425	0.00425	CcSEcCtD
Nafarelin—Pleural effusion—Doxorubicin—sarcoma	0.00422	0.00422	CcSEcCtD
Nafarelin—Myocardial infarction—Vincristine—sarcoma	0.00422	0.00422	CcSEcCtD
Nafarelin—Liver injury—Epirubicin—sarcoma	0.00416	0.00416	CcSEcCtD
Nafarelin—Acute coronary syndrome—Mitoxantrone—sarcoma	0.00414	0.00414	CcSEcCtD
Nafarelin—Myocardial infarction—Mitoxantrone—sarcoma	0.00411	0.00411	CcSEcCtD
Nafarelin—Conjunctivitis—Mitoxantrone—sarcoma	0.00408	0.00408	CcSEcCtD
Nafarelin—Breast pain—Epirubicin—sarcoma	0.00401	0.00401	CcSEcCtD
Nafarelin—Sinusitis—Mitoxantrone—sarcoma	0.00394	0.00394	CcSEcCtD
Nafarelin—Alopecia—Thiotepa—sarcoma	0.00385	0.00385	CcSEcCtD
Nafarelin—Liver injury—Doxorubicin—sarcoma	0.00384	0.00384	CcSEcCtD
Nafarelin—Alopecia—Dactinomycin—sarcoma	0.00382	0.00382	CcSEcCtD
Nafarelin—Mental disorder—Thiotepa—sarcoma	0.00382	0.00382	CcSEcCtD
Nafarelin—Sweating increased—Etoposide—sarcoma	0.00381	0.00381	CcSEcCtD
Nafarelin—Malnutrition—Thiotepa—sarcoma	0.0038	0.0038	CcSEcCtD
Nafarelin—Oliguria—Epirubicin—sarcoma	0.00379	0.00379	CcSEcCtD
Nafarelin—Herpes simplex—Epirubicin—sarcoma	0.00379	0.00379	CcSEcCtD
Nafarelin—Rhinitis—Mitoxantrone—sarcoma	0.00378	0.00378	CcSEcCtD
Nafarelin—Tension—Thiotepa—sarcoma	0.00373	0.00373	CcSEcCtD
Nafarelin—Breast pain—Doxorubicin—sarcoma	0.00371	0.00371	CcSEcCtD
Nafarelin—Nervousness—Thiotepa—sarcoma	0.00369	0.00369	CcSEcCtD
Nafarelin—Coordination abnormal—Epirubicin—sarcoma	0.00356	0.00356	CcSEcCtD
Nafarelin—Oliguria—Doxorubicin—sarcoma	0.00351	0.00351	CcSEcCtD
Nafarelin—Herpes simplex—Doxorubicin—sarcoma	0.00351	0.00351	CcSEcCtD
Nafarelin—Pulmonary embolism—Epirubicin—sarcoma	0.0035	0.0035	CcSEcCtD
Nafarelin—Acute coronary syndrome—Etoposide—sarcoma	0.00344	0.00344	CcSEcCtD
Nafarelin—Myocardial infarction—Etoposide—sarcoma	0.00342	0.00342	CcSEcCtD
Nafarelin—Alopecia—Vincristine—sarcoma	0.00342	0.00342	CcSEcCtD
Nafarelin—Cystitis noninfective—Epirubicin—sarcoma	0.00342	0.00342	CcSEcCtD
Nafarelin—Mental disorder—Vincristine—sarcoma	0.00339	0.00339	CcSEcCtD
Nafarelin—Cystitis—Epirubicin—sarcoma	0.00338	0.00338	CcSEcCtD
Nafarelin—Alopecia—Mitoxantrone—sarcoma	0.00333	0.00333	CcSEcCtD
Nafarelin—Coordination abnormal—Doxorubicin—sarcoma	0.00329	0.00329	CcSEcCtD
Nafarelin—Convulsion—Thiotepa—sarcoma	0.00329	0.00329	CcSEcCtD
Nafarelin—Pulmonary embolism—Doxorubicin—sarcoma	0.00324	0.00324	CcSEcCtD
Nafarelin—Myalgia—Thiotepa—sarcoma	0.00323	0.00323	CcSEcCtD
Nafarelin—Arthralgia—Thiotepa—sarcoma	0.00323	0.00323	CcSEcCtD
Nafarelin—Dysgeusia—Mitoxantrone—sarcoma	0.00321	0.00321	CcSEcCtD
Nafarelin—Myalgia—Dactinomycin—sarcoma	0.00321	0.00321	CcSEcCtD
Nafarelin—Rash maculo-papular—Epirubicin—sarcoma	0.00318	0.00318	CcSEcCtD
Nafarelin—Bladder pain—Epirubicin—sarcoma	0.00316	0.00316	CcSEcCtD
Nafarelin—Neoplasm—Epirubicin—sarcoma	0.00316	0.00316	CcSEcCtD
Nafarelin—Cystitis noninfective—Doxorubicin—sarcoma	0.00316	0.00316	CcSEcCtD
Nafarelin—Cystitis—Doxorubicin—sarcoma	0.00312	0.00312	CcSEcCtD
Nafarelin—Oedema—Dactinomycin—sarcoma	0.00307	0.00307	CcSEcCtD
Nafarelin—Vertigo—Vincristine—sarcoma	0.00302	0.00302	CcSEcCtD
Nafarelin—Anorexia—Thiotepa—sarcoma	0.00295	0.00295	CcSEcCtD
Nafarelin—Rash maculo-papular—Doxorubicin—sarcoma	0.00294	0.00294	CcSEcCtD
Nafarelin—Anorexia—Dactinomycin—sarcoma	0.00293	0.00293	CcSEcCtD
Nafarelin—Neoplasm—Doxorubicin—sarcoma	0.00293	0.00293	CcSEcCtD
Nafarelin—Bladder pain—Doxorubicin—sarcoma	0.00293	0.00293	CcSEcCtD
Nafarelin—Convulsion—Vincristine—sarcoma	0.00292	0.00292	CcSEcCtD
Nafarelin—Hepatic function abnormal—Epirubicin—sarcoma	0.0029	0.0029	CcSEcCtD
Nafarelin—Myalgia—Vincristine—sarcoma	0.00287	0.00287	CcSEcCtD
Nafarelin—Convulsion—Mitoxantrone—sarcoma	0.00284	0.00284	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Thiotepa—sarcoma	0.00282	0.00282	CcSEcCtD
Nafarelin—Eye pain—Epirubicin—sarcoma	0.00281	0.00281	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.0028	0.0028	CcSEcCtD
Nafarelin—Myalgia—Mitoxantrone—sarcoma	0.00279	0.00279	CcSEcCtD
Nafarelin—Chest pain—Mitoxantrone—sarcoma	0.00279	0.00279	CcSEcCtD
Nafarelin—Arthralgia—Mitoxantrone—sarcoma	0.00279	0.00279	CcSEcCtD
Nafarelin—Paraesthesia—Thiotepa—sarcoma	0.00278	0.00278	CcSEcCtD
Nafarelin—Alopecia—Etoposide—sarcoma	0.00277	0.00277	CcSEcCtD
Nafarelin—Oedema—Vincristine—sarcoma	0.00275	0.00275	CcSEcCtD
Nafarelin—Hot flush—Epirubicin—sarcoma	0.00271	0.00271	CcSEcCtD
Nafarelin—Increased appetite—Epirubicin—sarcoma	0.0027	0.0027	CcSEcCtD
Nafarelin—Decreased appetite—Thiotepa—sarcoma	0.00269	0.00269	CcSEcCtD
Nafarelin—Menopausal symptoms—Epirubicin—sarcoma	0.00269	0.00269	CcSEcCtD
Nafarelin—Hepatic function abnormal—Doxorubicin—sarcoma	0.00269	0.00269	CcSEcCtD
Nafarelin—Oedema—Mitoxantrone—sarcoma	0.00268	0.00268	CcSEcCtD
Nafarelin—Decreased appetite—Dactinomycin—sarcoma	0.00267	0.00267	CcSEcCtD
Nafarelin—Dysgeusia—Etoposide—sarcoma	0.00267	0.00267	CcSEcCtD
Nafarelin—Hyperhidrosis—Vincristine—sarcoma	0.00266	0.00266	CcSEcCtD
Nafarelin—Constipation—Thiotepa—sarcoma	0.00265	0.00265	CcSEcCtD
Nafarelin—Shock—Mitoxantrone—sarcoma	0.00263	0.00263	CcSEcCtD
Nafarelin—Anorexia—Vincristine—sarcoma	0.00262	0.00262	CcSEcCtD
Nafarelin—Eye pain—Doxorubicin—sarcoma	0.0026	0.0026	CcSEcCtD
Nafarelin—Cerebrovascular accident—Epirubicin—sarcoma	0.00259	0.00259	CcSEcCtD
Nafarelin—Hyperhidrosis—Mitoxantrone—sarcoma	0.00259	0.00259	CcSEcCtD
Nafarelin—Anorexia—Mitoxantrone—sarcoma	0.00255	0.00255	CcSEcCtD
Nafarelin—Hot flush—Doxorubicin—sarcoma	0.00251	0.00251	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Vincristine—sarcoma	0.0025	0.0025	CcSEcCtD
Nafarelin—Increased appetite—Doxorubicin—sarcoma	0.0025	0.0025	CcSEcCtD
Nafarelin—Affect lability—Epirubicin—sarcoma	0.0025	0.0025	CcSEcCtD
Nafarelin—Menopausal symptoms—Doxorubicin—sarcoma	0.00249	0.00249	CcSEcCtD
Nafarelin—Insomnia—Vincristine—sarcoma	0.00248	0.00248	CcSEcCtD
Nafarelin—Paraesthesia—Vincristine—sarcoma	0.00247	0.00247	CcSEcCtD
Nafarelin—Urticaria—Thiotepa—sarcoma	0.00246	0.00246	CcSEcCtD
Nafarelin—Vertigo—Etoposide—sarcoma	0.00245	0.00245	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00244	0.00244	CcSEcCtD
Nafarelin—Mood swings—Epirubicin—sarcoma	0.0024	0.0024	CcSEcCtD
Nafarelin—Paraesthesia—Mitoxantrone—sarcoma	0.0024	0.0024	CcSEcCtD
Nafarelin—Cerebrovascular accident—Doxorubicin—sarcoma	0.0024	0.0024	CcSEcCtD
Nafarelin—Decreased appetite—Vincristine—sarcoma	0.00239	0.00239	CcSEcCtD
Nafarelin—Dyspnoea—Mitoxantrone—sarcoma	0.00239	0.00239	CcSEcCtD
Nafarelin—Convulsion—Etoposide—sarcoma	0.00236	0.00236	CcSEcCtD
Nafarelin—Constipation—Vincristine—sarcoma	0.00235	0.00235	CcSEcCtD
Nafarelin—Dry skin—Epirubicin—sarcoma	0.00233	0.00233	CcSEcCtD
Nafarelin—Decreased appetite—Mitoxantrone—sarcoma	0.00233	0.00233	CcSEcCtD
Nafarelin—Chest pain—Etoposide—sarcoma	0.00232	0.00232	CcSEcCtD
Nafarelin—Affect lability—Doxorubicin—sarcoma	0.00231	0.00231	CcSEcCtD
Nafarelin—Constipation—Mitoxantrone—sarcoma	0.00229	0.00229	CcSEcCtD
Nafarelin—Gastritis—Epirubicin—sarcoma	0.00225	0.00225	CcSEcCtD
Nafarelin—Muscular weakness—Epirubicin—sarcoma	0.00224	0.00224	CcSEcCtD
Nafarelin—Mood swings—Doxorubicin—sarcoma	0.00222	0.00222	CcSEcCtD
Nafarelin—Asthenia—Thiotepa—sarcoma	0.00222	0.00222	CcSEcCtD
Nafarelin—Abdominal distension—Epirubicin—sarcoma	0.00221	0.00221	CcSEcCtD
Nafarelin—Asthenia—Dactinomycin—sarcoma	0.00221	0.00221	CcSEcCtD
Nafarelin—Pruritus—Thiotepa—sarcoma	0.00219	0.00219	CcSEcCtD
Nafarelin—Dry skin—Doxorubicin—sarcoma	0.00215	0.00215	CcSEcCtD
Nafarelin—Hyperhidrosis—Etoposide—sarcoma	0.00215	0.00215	CcSEcCtD
Nafarelin—Urticaria—Mitoxantrone—sarcoma	0.00213	0.00213	CcSEcCtD
Nafarelin—Anorexia—Etoposide—sarcoma	0.00212	0.00212	CcSEcCtD
Nafarelin—Diarrhoea—Thiotepa—sarcoma	0.00212	0.00212	CcSEcCtD
Nafarelin—Diarrhoea—Dactinomycin—sarcoma	0.0021	0.0021	CcSEcCtD
Nafarelin—Gastritis—Doxorubicin—sarcoma	0.00208	0.00208	CcSEcCtD
Nafarelin—Muscular weakness—Doxorubicin—sarcoma	0.00207	0.00207	CcSEcCtD
Nafarelin—Dysuria—Epirubicin—sarcoma	0.00205	0.00205	CcSEcCtD
Nafarelin—Dizziness—Thiotepa—sarcoma	0.00205	0.00205	CcSEcCtD
Nafarelin—Abdominal distension—Doxorubicin—sarcoma	0.00204	0.00204	CcSEcCtD
Nafarelin—Paraesthesia—Etoposide—sarcoma	0.002	0.002	CcSEcCtD
Nafarelin—Weight increased—Epirubicin—sarcoma	0.002	0.002	CcSEcCtD
Nafarelin—Weight decreased—Epirubicin—sarcoma	0.00198	0.00198	CcSEcCtD
Nafarelin—Dyspnoea—Etoposide—sarcoma	0.00198	0.00198	CcSEcCtD
Nafarelin—Asthenia—Vincristine—sarcoma	0.00197	0.00197	CcSEcCtD
Nafarelin—Vomiting—Thiotepa—sarcoma	0.00197	0.00197	CcSEcCtD
Nafarelin—Vomiting—Dactinomycin—sarcoma	0.00196	0.00196	CcSEcCtD
Nafarelin—Rash—Thiotepa—sarcoma	0.00195	0.00195	CcSEcCtD
Nafarelin—Dermatitis—Thiotepa—sarcoma	0.00195	0.00195	CcSEcCtD
Nafarelin—Headache—Thiotepa—sarcoma	0.00194	0.00194	CcSEcCtD
Nafarelin—Rash—Dactinomycin—sarcoma	0.00194	0.00194	CcSEcCtD
Nafarelin—Decreased appetite—Etoposide—sarcoma	0.00193	0.00193	CcSEcCtD
Nafarelin—Asthenia—Mitoxantrone—sarcoma	0.00192	0.00192	CcSEcCtD
Nafarelin—Constipation—Etoposide—sarcoma	0.0019	0.0019	CcSEcCtD
Nafarelin—Conjunctivitis—Epirubicin—sarcoma	0.0019	0.0019	CcSEcCtD
Nafarelin—Dysuria—Doxorubicin—sarcoma	0.0019	0.0019	CcSEcCtD
Nafarelin—Diarrhoea—Vincristine—sarcoma	0.00188	0.00188	CcSEcCtD
Nafarelin—Weight increased—Doxorubicin—sarcoma	0.00185	0.00185	CcSEcCtD
Nafarelin—Epistaxis—Epirubicin—sarcoma	0.00184	0.00184	CcSEcCtD
Nafarelin—Nausea—Thiotepa—sarcoma	0.00184	0.00184	CcSEcCtD
Nafarelin—Weight decreased—Doxorubicin—sarcoma	0.00184	0.00184	CcSEcCtD
Nafarelin—Sinusitis—Epirubicin—sarcoma	0.00184	0.00184	CcSEcCtD
Nafarelin—Diarrhoea—Mitoxantrone—sarcoma	0.00183	0.00183	CcSEcCtD
Nafarelin—Nausea—Dactinomycin—sarcoma	0.00183	0.00183	CcSEcCtD
Nafarelin—Dizziness—Vincristine—sarcoma	0.00182	0.00182	CcSEcCtD
Nafarelin—Urticaria—Etoposide—sarcoma	0.00177	0.00177	CcSEcCtD
Nafarelin—Rhinitis—Epirubicin—sarcoma	0.00176	0.00176	CcSEcCtD
Nafarelin—Conjunctivitis—Doxorubicin—sarcoma	0.00176	0.00176	CcSEcCtD
Nafarelin—Vomiting—Vincristine—sarcoma	0.00175	0.00175	CcSEcCtD
Nafarelin—Rash—Vincristine—sarcoma	0.00173	0.00173	CcSEcCtD
Nafarelin—Dermatitis—Vincristine—sarcoma	0.00173	0.00173	CcSEcCtD
Nafarelin—Headache—Vincristine—sarcoma	0.00172	0.00172	CcSEcCtD
Nafarelin—Epistaxis—Doxorubicin—sarcoma	0.00171	0.00171	CcSEcCtD
Nafarelin—Vomiting—Mitoxantrone—sarcoma	0.0017	0.0017	CcSEcCtD
Nafarelin—Sinusitis—Doxorubicin—sarcoma	0.0017	0.0017	CcSEcCtD
Nafarelin—Rash—Mitoxantrone—sarcoma	0.00169	0.00169	CcSEcCtD
Nafarelin—Dermatitis—Mitoxantrone—sarcoma	0.00169	0.00169	CcSEcCtD
Nafarelin—Headache—Mitoxantrone—sarcoma	0.00168	0.00168	CcSEcCtD
Nafarelin—Nausea—Vincristine—sarcoma	0.00163	0.00163	CcSEcCtD
Nafarelin—Rhinitis—Doxorubicin—sarcoma	0.00163	0.00163	CcSEcCtD
Nafarelin—Asthenia—Etoposide—sarcoma	0.0016	0.0016	CcSEcCtD
Nafarelin—Nausea—Mitoxantrone—sarcoma	0.00159	0.00159	CcSEcCtD
Nafarelin—Pruritus—Etoposide—sarcoma	0.00157	0.00157	CcSEcCtD
Nafarelin—Alopecia—Epirubicin—sarcoma	0.00155	0.00155	CcSEcCtD
Nafarelin—Mental disorder—Epirubicin—sarcoma	0.00154	0.00154	CcSEcCtD
Nafarelin—Malnutrition—Epirubicin—sarcoma	0.00153	0.00153	CcSEcCtD
Nafarelin—Diarrhoea—Etoposide—sarcoma	0.00152	0.00152	CcSEcCtD
Nafarelin—Tension—Epirubicin—sarcoma	0.0015	0.0015	CcSEcCtD
Nafarelin—Dysgeusia—Epirubicin—sarcoma	0.0015	0.0015	CcSEcCtD
Nafarelin—Nervousness—Epirubicin—sarcoma	0.00148	0.00148	CcSEcCtD
Nafarelin—Dizziness—Etoposide—sarcoma	0.00147	0.00147	CcSEcCtD
Nafarelin—Alopecia—Doxorubicin—sarcoma	0.00144	0.00144	CcSEcCtD
Nafarelin—Mental disorder—Doxorubicin—sarcoma	0.00142	0.00142	CcSEcCtD
Nafarelin—Vomiting—Etoposide—sarcoma	0.00141	0.00141	CcSEcCtD
Nafarelin—Malnutrition—Doxorubicin—sarcoma	0.00141	0.00141	CcSEcCtD
Nafarelin—Rash—Etoposide—sarcoma	0.0014	0.0014	CcSEcCtD
Nafarelin—Dermatitis—Etoposide—sarcoma	0.0014	0.0014	CcSEcCtD
Nafarelin—Headache—Etoposide—sarcoma	0.00139	0.00139	CcSEcCtD
Nafarelin—Tension—Doxorubicin—sarcoma	0.00139	0.00139	CcSEcCtD
Nafarelin—Dysgeusia—Doxorubicin—sarcoma	0.00138	0.00138	CcSEcCtD
Nafarelin—Nervousness—Doxorubicin—sarcoma	0.00137	0.00137	CcSEcCtD
Nafarelin—Vertigo—Epirubicin—sarcoma	0.00137	0.00137	CcSEcCtD
Nafarelin—Palpitations—Epirubicin—sarcoma	0.00135	0.00135	CcSEcCtD
Nafarelin—Convulsion—Epirubicin—sarcoma	0.00132	0.00132	CcSEcCtD
Nafarelin—Nausea—Etoposide—sarcoma	0.00132	0.00132	CcSEcCtD
Nafarelin—Arthralgia—Epirubicin—sarcoma	0.0013	0.0013	CcSEcCtD
Nafarelin—Chest pain—Epirubicin—sarcoma	0.0013	0.0013	CcSEcCtD
Nafarelin—Myalgia—Epirubicin—sarcoma	0.0013	0.0013	CcSEcCtD
Nafarelin—Vertigo—Doxorubicin—sarcoma	0.00127	0.00127	CcSEcCtD
Nafarelin—Palpitations—Doxorubicin—sarcoma	0.00125	0.00125	CcSEcCtD
Nafarelin—Oedema—Epirubicin—sarcoma	0.00125	0.00125	CcSEcCtD
Nafarelin—Shock—Epirubicin—sarcoma	0.00123	0.00123	CcSEcCtD
Nafarelin—Convulsion—Doxorubicin—sarcoma	0.00123	0.00123	CcSEcCtD
Nafarelin—Hyperhidrosis—Epirubicin—sarcoma	0.00121	0.00121	CcSEcCtD
Nafarelin—Arthralgia—Doxorubicin—sarcoma	0.0012	0.0012	CcSEcCtD
Nafarelin—Myalgia—Doxorubicin—sarcoma	0.0012	0.0012	CcSEcCtD
Nafarelin—Chest pain—Doxorubicin—sarcoma	0.0012	0.0012	CcSEcCtD
Nafarelin—Anorexia—Epirubicin—sarcoma	0.00119	0.00119	CcSEcCtD
Nafarelin—Oedema—Doxorubicin—sarcoma	0.00115	0.00115	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Epirubicin—sarcoma	0.00114	0.00114	CcSEcCtD
Nafarelin—Shock—Doxorubicin—sarcoma	0.00114	0.00114	CcSEcCtD
Nafarelin—Insomnia—Epirubicin—sarcoma	0.00113	0.00113	CcSEcCtD
Nafarelin—Paraesthesia—Epirubicin—sarcoma	0.00112	0.00112	CcSEcCtD
Nafarelin—Hyperhidrosis—Doxorubicin—sarcoma	0.00112	0.00112	CcSEcCtD
Nafarelin—Dyspnoea—Epirubicin—sarcoma	0.00111	0.00111	CcSEcCtD
Nafarelin—Anorexia—Doxorubicin—sarcoma	0.0011	0.0011	CcSEcCtD
Nafarelin—Decreased appetite—Epirubicin—sarcoma	0.00108	0.00108	CcSEcCtD
Nafarelin—Constipation—Epirubicin—sarcoma	0.00107	0.00107	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.00105	0.00105	CcSEcCtD
Nafarelin—Insomnia—Doxorubicin—sarcoma	0.00104	0.00104	CcSEcCtD
Nafarelin—Paraesthesia—Doxorubicin—sarcoma	0.00104	0.00104	CcSEcCtD
Nafarelin—Dyspnoea—Doxorubicin—sarcoma	0.00103	0.00103	CcSEcCtD
Nafarelin—Decreased appetite—Doxorubicin—sarcoma	0.001	0.001	CcSEcCtD
Nafarelin—Urticaria—Epirubicin—sarcoma	0.000991	0.000991	CcSEcCtD
Nafarelin—Constipation—Doxorubicin—sarcoma	0.000987	0.000987	CcSEcCtD
Nafarelin—Urticaria—Doxorubicin—sarcoma	0.000917	0.000917	CcSEcCtD
Nafarelin—Asthenia—Epirubicin—sarcoma	0.000895	0.000895	CcSEcCtD
Nafarelin—Pruritus—Epirubicin—sarcoma	0.000883	0.000883	CcSEcCtD
Nafarelin—Diarrhoea—Epirubicin—sarcoma	0.000854	0.000854	CcSEcCtD
Nafarelin—Asthenia—Doxorubicin—sarcoma	0.000828	0.000828	CcSEcCtD
Nafarelin—Dizziness—Epirubicin—sarcoma	0.000825	0.000825	CcSEcCtD
Nafarelin—Pruritus—Doxorubicin—sarcoma	0.000817	0.000817	CcSEcCtD
Nafarelin—Vomiting—Epirubicin—sarcoma	0.000793	0.000793	CcSEcCtD
Nafarelin—Diarrhoea—Doxorubicin—sarcoma	0.00079	0.00079	CcSEcCtD
Nafarelin—Rash—Epirubicin—sarcoma	0.000787	0.000787	CcSEcCtD
Nafarelin—Dermatitis—Epirubicin—sarcoma	0.000786	0.000786	CcSEcCtD
Nafarelin—Headache—Epirubicin—sarcoma	0.000782	0.000782	CcSEcCtD
Nafarelin—Dizziness—Doxorubicin—sarcoma	0.000763	0.000763	CcSEcCtD
Nafarelin—Nausea—Epirubicin—sarcoma	0.000741	0.000741	CcSEcCtD
Nafarelin—Vomiting—Doxorubicin—sarcoma	0.000734	0.000734	CcSEcCtD
Nafarelin—Rash—Doxorubicin—sarcoma	0.000728	0.000728	CcSEcCtD
Nafarelin—Dermatitis—Doxorubicin—sarcoma	0.000727	0.000727	CcSEcCtD
Nafarelin—Headache—Doxorubicin—sarcoma	0.000723	0.000723	CcSEcCtD
Nafarelin—Nausea—Doxorubicin—sarcoma	0.000686	0.000686	CcSEcCtD
